Only a small percentage of people with early dementia eligible for new Alzheimer's drugs
Only a small percentage of older adults who are in the early stages of Alzheimer's disease meet the eligibility criteria to receive new monoclonal antibody treatments, drugs that target amyloid-ß plaques in the brain, an ...
Aug 16, 2023
0
16